Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa

Ndwiga L. et al, (2021), International Journal for Parasitology: Drugs and Drug Resistance, 16, 155 - 161

Therapeutic vaccination for treatment of chronic hepatitis B.

Cargill T. and Barnes E., (2021), Clinical and experimental immunology, 205, 106 - 118

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil; an exploratory analysis of a randomised controlled trial

Clemens SC. et al, (2021)

Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites

Kolli SK. et al, (2021), PLOS ONE, 16, e0254498 - e0254498

Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.

Allen JD. et al, (2021), Biochemistry

A salmonella typhi controlled human infection study for assessing correlation between bactericidal antibodies and protection against infection induced by typhoid vaccination

Jones E. et al, (2021), Microorganisms, 9

Dissection-independent production of Plasmodium sporozoites from whole mosquitoes.

Blight J. et al, (2021), Life science alliance, 4

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study.

Wang T. et al, (2021), BMC infectious diseases, 21

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.

Adetifa IMO. et al, (2021), Nature communications, 12

Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.

Redhead MA. et al, (2021), Scientific reports, 11

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Feng S. et al, (2021)

SARS-CoV-2 Variants and Vaccines.

Krause PR. et al, (2021), The New England journal of medicine

T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.

Swanson PA. et al, (2021), medRxiv

COVID-19 Transmission Dynamics Underlying Epidemic Waves in Kenya

Brand S. et al, (2021)

Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity.

Chauveau L. et al, (2021), EMBO Rep

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

Liu C. et al, (2021), Cell

Assessing the level and determinants of COVID-19 Vaccine Confidence in Kenya

Orangi S. et al, (2021)

Divergent trajectories of antiviral memory after SARS-Cov-2 infection

Tomic* A. et al, (2021)

Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery.

Peterhoff D. et al, (2021), Vaccines, 9

High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation.

Sibley L. et al, (2021), Scientific reports, 11

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?